Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings Routine +

AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500

AI/ML Innovations Secures Funding Amidst Dilutive Debt Settlements

By The Northwire Desk — AI Analysis May 11, 2026 · 22:20 AIML · 0.06 AI-ML Innovations Inc.
Executive Summary
  • Financing Completion: The company closed the second and final tranche of a private placement, raising $1,917,500 in convertible debentures.
  • Total Capital Raised: Combined with the first tranche ($950,000), total aggregate principal is $2,867,500.
  • Instrument Terms: Debentures convert into Units at $0.05 per Unit (1 share + 1 warrant). Warrants exercise at $0.15 for 36 months. Interest rate is 10% per annum. Maturity is May 2029.
  • Insider Participation: Insiders purchased $340,000 of the debentures in this tranche (total insider participation across tranches was ~$890,000).
  • Regulatory Status: Offering subject to final approval from the Canadian Securities Exchange (CSE).
  • Debt Settlement Context: This follows a significant debt settlement in April 2026 where 17 million shares were issued at $0.05 to settle ~$855,921 of indebtedness, heavily weighted toward insiders.
Material Impact
  • Capitalization vs. Dilution: The raise provides essential working capital (~$2.8M total), but the conversion price ($0.05) is below the current trading price ($0.06). This creates immediate dilution pressure if holders convert, though warrants at $0.15 provide a buffer for now.
  • Expected Nature: The financing was proposed on March 12, 2026, and closed May 11, 2026. As the terms were public months prior, this is not unexpected market-moving information but rather the execution of a known plan.
  • Insider Alignment vs. Dilution: While insider participation ($890k total) signals confidence, it occurred alongside a massive share issuance for debt settlement (17M shares @ $0.05). The net effect is significant dilution to existing shareholders without immediate revenue offset.
  • Liquidity Risk Mitigation: The cash infusion extends the runway, reducing near-term bankruptcy risk, but does not solve the fundamental lack of commercial revenue or regulatory clearance for flagship products (CardioYield).
AIML · Price
Company Overview
  • Core Business: AI/ML Innovations Inc. focuses on digital health platforms converting biometric data into clinical insights via its subsidiary NeuralCloud Solutions.
  • Flagship Products: MaxYield™ (ECG signal-processing engine) and CardioYield™ (AI-powered Holter reporting software).
  • Development Stage: Pre-revenue / Pilot Phase. Multiple pilots launched in Jamaica, Canada, and with US partners (Movesense), but no commercial revenue disclosed.
  • Intellectual Property: Granted U.S. Patent No. 12,465,266 in November 2025 protecting core ECG signal-processing architecture.
  • Strategic Partnerships: Non-binding agreements with Movesense, Lakeshore Cardiology, Culminate H Labs, and Heartdent Center Ltd.
Read the original news release →

More from AI-ML Innovations Inc.

Jun 23, 2026 · 07:00

AI cardiac analytics pilot-stage company secures patent and settles debt via equity issuance.

Financings Apr 24, 2026 · 19:52

AIML Settles Debt with Equity as Liquidity Concerns Mount Amidst Unmonetized Pilots

Financings Apr 17, 2026 · 20:00

AI/ML Innovations Settles Debt with Equity Amidst Stagnant Valuation

Financings Mar 27, 2026 · 17:00

AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000

Financings Mar 12, 2026 · 19:30

AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures

Financings Feb 12, 2026 · 07:00

AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting

Production / Operations